EP3245602 - METHOD FOR INDIVIDUALIZED DRUG THERAPY [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 13.11.2020 Database last updated on 31.08.2024 | |
Former | Examination is in progress Status updated on 08.02.2020 | ||
Former | Request for examination was made Status updated on 20.10.2017 | ||
Former | The international publication has been made Status updated on 04.08.2017 | Most recent event Tooltip | 13.11.2020 | Application deemed to be withdrawn | published on 16.12.2020 [2020/51] | Applicant(s) | For all designated states Autotelic LLC 17870 Castleton Street, Suite 250 City of Industry, CA 91748 / US | [2017/47] | Inventor(s) | 01 /
TRIEU, Vuong 4003 Jim Bowie Agoura Hills, California 91301 / US | [2017/47] | Representative(s) | Grund, Martin Grund Intellectual Property Group Patentanwälte und Solicitor PartG mbB Steinsdorfstraße 2 80538 München / DE | [N/P] |
Former [2017/47] | Icosa 83 avenue Denfert-Rochereau 75014 Paris / FR | Application number, filing date | 15878203.7 | 13.01.2015 | [2017/47] | WO2015US11148 | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2016114761 | Date: | 21.07.2016 | Language: | EN | [2016/29] | Type: | A1 Application with search report | No.: | EP3245602 | Date: | 22.11.2017 | Language: | EN | The application published by WIPO in one of the EPO official languages on 21.07.2016 takes the place of the publication of the European patent application. | [2017/47] | Search report(s) | International search report - published on: | US | 21.07.2016 | (Supplementary) European search report - dispatched on: | EP | 06.08.2018 | Classification | IPC: | G06F19/00, A61K31/60, A61K31/415, A61P19/02, A61P29/00 | [2018/36] | CPC: |
A61K31/415 (EP,KR,US);
A61K31/616 (EP,KR);
A61K31/4155 (KR);
A61K31/5415 (KR);
A61K31/635 (EP,KR);
A61K45/06 (EP,KR);
A61K9/0053 (KR);
A61P1/00 (EP);
A61P11/00 (EP);
A61P11/02 (EP);
A61P13/00 (EP);
A61P13/12 (EP);
A61P15/00 (EP);
A61P15/14 (EP);
A61P17/00 (EP);
A61P19/02 (EP,KR);
A61P19/08 (EP);
A61P19/10 (EP);
A61P21/00 (EP);
A61P25/00 (EP);
A61P25/02 (EP);
A61P25/04 (EP);
A61P25/06 (EP);
A61P25/08 (EP);
A61P25/16 (EP);
A61P25/18 (EP);
A61P25/20 (EP);
A61P25/22 (EP);
A61P25/28 (EP);
A61P25/30 (EP);
A61P27/02 (EP);
A61P27/16 (EP);
A61P29/00 (EP);
A61P3/00 (EP);
A61P3/06 (EP);
A61P3/10 (EP);
A61P31/00 (EP);
A61P35/00 (EP);
A61P37/02 (EP);
A61P37/08 (EP);
A61P43/00 (EP);
A61P5/00 (EP);
A61P5/14 (EP);
A61P7/00 (EP);
A61P7/02 (EP);
A61P9/04 (EP);
A61P9/06 (EP);
A61P9/10 (EP);
A61P9/12 (EP);
G16C20/50 (EP,KR,US);
G16C99/00 (EP);
| C-Set: |
A61K31/415, A61K2300/00 (EP);
A61K31/616, A61K2300/00 (EP);
A61K31/635, A61K2300/00 (EP)
|
Former IPC [2017/47] | G06F19/00, A61K31/60, A61K31/415 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2017/47] | Title | German: | VERFAHREN FÜR INDIVIDUALISIERTE KREBSTHERAPIE | [2017/47] | English: | METHOD FOR INDIVIDUALIZED DRUG THERAPY | [2017/47] | French: | MÉTHODE POUR PHARMACOTHÉRAPIE INDIVIDUALISÉE | [2017/47] | Entry into regional phase | 14.08.2017 | National basic fee paid | 14.08.2017 | Search fee paid | 14.08.2017 | Designation fee(s) paid | 14.08.2017 | Examination fee paid | Examination procedure | 04.08.2017 | Date on which the examining division has become responsible | 14.08.2017 | Examination requested [2017/47] | 03.07.2019 | Amendment by applicant (claims and/or description) | 12.02.2020 | Despatch of a communication from the examining division (Time limit: M04) | 23.06.2020 | Application deemed to be withdrawn, date of legal effect [2020/51] | 11.08.2020 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2020/51] | Request for further processing for: | The application is deemed to be withdrawn due to failure to indicate the wish to proceed further with the application | 03.07.2019 | Request for further processing filed | 03.07.2019 | Full payment received (date of receipt of payment) Request granted | 18.07.2019 | Decision despatched | The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report | 03.07.2019 | Request for further processing filed | 03.07.2019 | Full payment received (date of receipt of payment) Request granted | 18.07.2019 | Decision despatched | Fees paid | Renewal fee | 14.08.2017 | Renewal fee patent year 03 | 31.01.2018 | Renewal fee patent year 04 | 31.01.2019 | Renewal fee patent year 05 | Penalty fee | Additional fee for renewal fee | 31.01.2020 | 06   M06   Not yet paid |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [X]US2004087640 (FERRO LEONARD J [US], et al) [X] 1-11 * paragraphs [0111] , [ 112] , [ 116] , [ 145] *; | [I] - HAMAMA AYMAN K ET AL, "Simultaneous determination of rofecoxib and celecoxib in human plasma by high-performance liquid chromatography", JOURNAL OF CHROMATOGRAPHIC SCIENCE, OXFORD UNIVERSITY PRESS, CARY, NC, USA, vol. 43, no. 7, doi:10.1093/CHROMSCI/43.7.351, ISSN 0021-9665, (20050731), pages 351 - 354, URL: https://epo.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV07T8MwELaABRbegvKSB1iQQp3Yjms2VCgMSCAoEkxWHCciqDRAqQT_nru4aVVggM2RzpZzZ-vu870I2WfSpoxZHfCWlIFQUgU243EgMhWrUFquGCY4P7RF91zdnIvLSZ3t7x58zZvp41v5DOqgKfiROuJVujSiBETmV_djcAWGsu9WgCEHcSxrD-ZvK0zpoEkSk89wm7IuKy3TWfrX_pbJ4siYpCde-itkJuuvkvl23cN, XP009506965 [I] 1-11 * Conclusions * DOI: http://dx.doi.org/10.1093/chromsci/43.7.351 | International search | [Y]US2006078621 (WEDINGER ROBERT S [US], et al) [Y] 1-11 * ; entire document, especially para [0001], [0004]-[0005], [0011]-[0012], [0017], [0019]-[0026], [0042], [0055]. *; | [Y]US2007202170 (DESAI SUBHASH [US], et al) [Y] 1-11 * ; entire document, especially para [0001], [0078], [0083], [0162]-[0163], [0165], [0389]-[0390], [0412]. *; | [Y]WO2012166795 (STRING THERAPEUTICS INC [US], et al) [Y] 3, (9-11)/(3)* ; entire document, especially pg 1, In 12-15; pg 2, In 29 to pg 3, In 3; pg 7, In 32-35; pg 8, In 9-11, 29-32; pg 12, In 14-33; pg 12, In 34 to pg 13, In 3. * |